Your browser doesn't support javascript.
loading
Phase 1 study of the immunotoxin LMB-100 in patients with mesothelioma and other solid tumors expressing mesothelin.
Hassan, Raffit; Alewine, Christine; Mian, Idrees; Spreafico, Anna; Siu, Lillian L; Gomez-Roca, Carlos; Delord, Jean-Pierre; Italiano, Antoine; Lassen, Ulrik; Soria, Jean-Charles; Bahleda, Rastilav; Thomas, Anish; Steinberg, Seth M; Peer, Cody J; Figg, William D; Niederfellner, Gerhard; Méresse Naegelen, Valérie; Pastan, Ira.
Afiliação
  • Hassan R; Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Alewine C; Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Mian I; Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Spreafico A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Siu LL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Gomez-Roca C; Clinical Research Unit, IUCT-Oncopole, Toulouse, France.
  • Delord JP; Clinical Research Unit, IUCT-Oncopole, Toulouse, France.
  • Italiano A; Department of Medicine, Bergonie Institute, Bordeaux, France.
  • Lassen U; Faculty of Medicine, University of Bordeaux, Bordeaux, France.
  • Soria JC; Department of Oncology, Rigshospitalet, Copenhagen, Denmark.
  • Bahleda R; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Thomas A; Gustave Roussy Institute, Villejuif, France.
  • Steinberg SM; University of Paris-South, Orsay, France.
  • Peer CJ; Gustave Roussy Institute, Villejuif, France.
  • Figg WD; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Niederfellner G; Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Méresse Naegelen V; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Pastan I; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Cancer ; 126(22): 4936-4947, 2020 11 15.
Article em En | MEDLINE | ID: mdl-32870522
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunotoxinas / Imunoconjugados / Proteínas Ligadas por GPI / Mesotelioma Limite: Humans / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunotoxinas / Imunoconjugados / Proteínas Ligadas por GPI / Mesotelioma Limite: Humans / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2020 Tipo de documento: Article